Back to TMO
Hennion & Walsh Asset Management, Inc. → TMO
Hennion & Walsh Asset Management, Inc. TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
9
Latest value
$2.9M
Q3 2026
Peak value
$48.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.5M |
| Q3 2025 | $835K |
| Q4 2025 | $3.9M |
| Q4 2025 | $524K |
| Q1 2026 | $3.4M |
| Q1 2026 | $693K |
| Q2 2026 | $2.8M |
| Q3 2026 | $48.7M |
| Q3 2026 | $2.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.9M | 4.3K | — | — |
| Q3 2026 | $48.7M | 915.2K | — | — |
| Q2 2026 | $2.8M | 5.5K | — | — |
| Q1 2026 | $693K | 13.7K | — | — |
| Q1 2026 | $3.4M | 6.9K | — | — |
| Q4 2025 | $524K | 14.1K | — | — |
| Q4 2025 | $3.9M | 6.8K | — | — |
| Q3 2025 | $835K | 31.3K | — | — |
| Q3 2025 | $2.5M | 5.2K | — | — |
Other funds holding TMO
$17.6B
$15.8B
$14.7B
$10.1B
$9.6B
$9.6B